Atlas Trials

Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer Patients

Clinical trial NCT03974594 · COMPLETED

Trial details

NCT number
NCT03974594
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2019-05-21
Primary completion
2019-07-16
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.